Inventor

MEININGHAUS MARK

DE11 patents

⚠️ This page may combine multiple inventors who share the name “MEININGHAUS MARK”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

Bayer Pharma AG

4 patents

US10435403B2Oct 8, 2019

Positive allosteric modulators of muscarinic M2 receptor

Bayer Pharma AG7 citations70

US10479765B2Nov 19, 2019

Substituted N,2-diarylquinoline-4-carboxamides and the use thereof as anti-inflammatory agents

Bayer Pharma AG0 citations51

US10189788B2Jan 29, 2019

Substituted N,2-diarylquinoline-4-carboxamides and the use thereof as anti-inflammatory agents

Bayer Pharma AG0 citations51

US10117864B2Nov 6, 2018

Substituted N-bicyclo-2-aryl-quinolin-4-carboxamides and use thereof

Bayer Pharma AG0 citations39

LAMPE THOMAS

2 patents

US8183246B2May 22, 2012

Acyclically substituted furopyrimidine derivatives and use thereof

LAMPE THOMAS1 citations50

US8324222B2Dec 4, 2012

Cyclically substituted furopyrimidine derivatives and use thereof

LAMPE THOMAS0 citations39

BAYER AG

2 patents

US11149018B2Oct 19, 2021

Substituted N-arylethyl-2-aminoquinoline-4-carboxamides and use thereof

BAYER AG0 citations47

US11136296B2Oct 5, 2021

Substituted N-arylethyl-2-arylquinoline-4-carboxamides and use thereof

BAYER AG0 citations47

HEIMBACH DIRK

1 patent

US8119663B2Feb 21, 2012

Heteroaryl-substituted piperidines

HEIMBACH DIRK16 citations81

BAYER SCHERING PHARMA AG

1 patent

US7776922B2Aug 17, 2010

Substituted [(phenylethanoyl)amino]benzamides

BAYER SCHERING PHARMA AG16 citations81

JESKE MARIO

1 patent

US8987248B2Mar 24, 2015

Substituted piperidines as Par-1 antagonists

JESKE MARIO1 citations49